nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—ABCB1—Vismodegib—skin cancer	0.16	0.557	CbGbCtD
Naltrexone—ABCB1—Dactinomycin—skin cancer	0.0842	0.292	CbGbCtD
Naltrexone—ABCB1—Docetaxel—skin cancer	0.0435	0.151	CbGbCtD
Naltrexone—Chills—Dactinomycin—skin cancer	0.000982	0.00138	CcSEcCtD
Naltrexone—Pruritus—Vemurafenib—skin cancer	0.000973	0.00137	CcSEcCtD
Naltrexone—Connective tissue disorder—Temozolomide—skin cancer	0.000973	0.00137	CcSEcCtD
Naltrexone—Lethargy—Docetaxel—skin cancer	0.000971	0.00136	CcSEcCtD
Naltrexone—Alopecia—Dactinomycin—skin cancer	0.000967	0.00136	CcSEcCtD
Naltrexone—Feeling abnormal—Imiquimod—skin cancer	0.000967	0.00136	CcSEcCtD
Naltrexone—Gastrointestinal pain—Imiquimod—skin cancer	0.000959	0.00135	CcSEcCtD
Naltrexone—Epistaxis—Fluorouracil—skin cancer	0.000958	0.00135	CcSEcCtD
Naltrexone—Sinusitis—Fluorouracil—skin cancer	0.000953	0.00134	CcSEcCtD
Naltrexone—Pain in extremity—Docetaxel—skin cancer	0.000951	0.00134	CcSEcCtD
Naltrexone—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000951	0.00134	CcSEcCtD
Naltrexone—Ill-defined disorder—Bleomycin—skin cancer	0.000948	0.00133	CcSEcCtD
Naltrexone—Diarrhoea—Vemurafenib—skin cancer	0.000941	0.00132	CcSEcCtD
Naltrexone—Migraine—Docetaxel—skin cancer	0.000936	0.00132	CcSEcCtD
Naltrexone—Urticaria—Imiquimod—skin cancer	0.000932	0.00131	CcSEcCtD
Naltrexone—Abdominal pain—Imiquimod—skin cancer	0.000928	0.0013	CcSEcCtD
Naltrexone—Body temperature increased—Imiquimod—skin cancer	0.000928	0.0013	CcSEcCtD
Naltrexone—Eye disorder—Temozolomide—skin cancer	0.000925	0.0013	CcSEcCtD
Naltrexone—Tinnitus—Temozolomide—skin cancer	0.000923	0.0013	CcSEcCtD
Naltrexone—Malaise—Bleomycin—skin cancer	0.000921	0.00129	CcSEcCtD
Naltrexone—Cardiac disorder—Temozolomide—skin cancer	0.000919	0.00129	CcSEcCtD
Naltrexone—Dizziness—Vemurafenib—skin cancer	0.00091	0.00128	CcSEcCtD
Naltrexone—Pharyngitis—Fluorouracil—skin cancer	0.000905	0.00127	CcSEcCtD
Naltrexone—Angiopathy—Temozolomide—skin cancer	0.000898	0.00126	CcSEcCtD
Naltrexone—Immune system disorder—Temozolomide—skin cancer	0.000894	0.00126	CcSEcCtD
Naltrexone—Mediastinal disorder—Temozolomide—skin cancer	0.000892	0.00125	CcSEcCtD
Naltrexone—Cough—Bleomycin—skin cancer	0.000891	0.00125	CcSEcCtD
Naltrexone—Chills—Temozolomide—skin cancer	0.000888	0.00125	CcSEcCtD
Naltrexone—Dehydration—Docetaxel—skin cancer	0.000885	0.00124	CcSEcCtD
Naltrexone—Ill-defined disorder—Dactinomycin—skin cancer	0.000884	0.00124	CcSEcCtD
Naltrexone—Vomiting—Vemurafenib—skin cancer	0.000875	0.00123	CcSEcCtD
Naltrexone—Alopecia—Temozolomide—skin cancer	0.000875	0.00123	CcSEcCtD
Naltrexone—Chest pain—Bleomycin—skin cancer	0.00087	0.00122	CcSEcCtD
Naltrexone—Myalgia—Bleomycin—skin cancer	0.00087	0.00122	CcSEcCtD
Naltrexone—Abdominal pain upper—Docetaxel—skin cancer	0.000869	0.00122	CcSEcCtD
Naltrexone—Rash—Vemurafenib—skin cancer	0.000867	0.00122	CcSEcCtD
Naltrexone—Mental disorder—Temozolomide—skin cancer	0.000867	0.00122	CcSEcCtD
Naltrexone—Dermatitis—Vemurafenib—skin cancer	0.000867	0.00122	CcSEcCtD
Naltrexone—Hypersensitivity—Imiquimod—skin cancer	0.000864	0.00121	CcSEcCtD
Naltrexone—Headache—Vemurafenib—skin cancer	0.000862	0.00121	CcSEcCtD
Naltrexone—Malnutrition—Temozolomide—skin cancer	0.000862	0.00121	CcSEcCtD
Naltrexone—Discomfort—Bleomycin—skin cancer	0.000859	0.00121	CcSEcCtD
Naltrexone—Malaise—Dactinomycin—skin cancer	0.000859	0.00121	CcSEcCtD
Naltrexone—Cramp muscle—Docetaxel—skin cancer	0.000857	0.0012	CcSEcCtD
Naltrexone—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000857	0.0012	CcSEcCtD
Naltrexone—Nasopharyngitis—Docetaxel—skin cancer	0.000851	0.00119	CcSEcCtD
Naltrexone—Dysgeusia—Temozolomide—skin cancer	0.000844	0.00118	CcSEcCtD
Naltrexone—Asthenia—Imiquimod—skin cancer	0.000842	0.00118	CcSEcCtD
Naltrexone—Confusional state—Bleomycin—skin cancer	0.00084	0.00118	CcSEcCtD
Naltrexone—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000839	0.00118	CcSEcCtD
Naltrexone—Oedema—Bleomycin—skin cancer	0.000834	0.00117	CcSEcCtD
Naltrexone—Anaphylactic shock—Bleomycin—skin cancer	0.000834	0.00117	CcSEcCtD
Naltrexone—Back pain—Temozolomide—skin cancer	0.000833	0.00117	CcSEcCtD
Naltrexone—Pruritus—Imiquimod—skin cancer	0.00083	0.00117	CcSEcCtD
Naltrexone—Infection—Bleomycin—skin cancer	0.000828	0.00116	CcSEcCtD
Naltrexone—Nausea—Vemurafenib—skin cancer	0.000817	0.00115	CcSEcCtD
Naltrexone—Vision blurred—Temozolomide—skin cancer	0.000812	0.00114	CcSEcCtD
Naltrexone—Myalgia—Dactinomycin—skin cancer	0.000811	0.00114	CcSEcCtD
Naltrexone—Tremor—Temozolomide—skin cancer	0.000807	0.00113	CcSEcCtD
Naltrexone—Alopecia—Fluorouracil—skin cancer	0.000806	0.00113	CcSEcCtD
Naltrexone—Diarrhoea—Imiquimod—skin cancer	0.000803	0.00113	CcSEcCtD
Naltrexone—Discomfort—Dactinomycin—skin cancer	0.000801	0.00113	CcSEcCtD
Naltrexone—Angina pectoris—Docetaxel—skin cancer	0.000801	0.00112	CcSEcCtD
Naltrexone—Ill-defined disorder—Temozolomide—skin cancer	0.000799	0.00112	CcSEcCtD
Naltrexone—Anorexia—Bleomycin—skin cancer	0.000795	0.00112	CcSEcCtD
Naltrexone—Agitation—Temozolomide—skin cancer	0.000792	0.00111	CcSEcCtD
Naltrexone—Angioedema—Temozolomide—skin cancer	0.000787	0.00111	CcSEcCtD
Naltrexone—Oedema—Dactinomycin—skin cancer	0.000777	0.00109	CcSEcCtD
Naltrexone—Malaise—Temozolomide—skin cancer	0.000777	0.00109	CcSEcCtD
Naltrexone—Dizziness—Imiquimod—skin cancer	0.000776	0.00109	CcSEcCtD
Naltrexone—Infection—Dactinomycin—skin cancer	0.000772	0.00108	CcSEcCtD
Naltrexone—Palpitations—Temozolomide—skin cancer	0.000761	0.00107	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000759	0.00107	CcSEcCtD
Naltrexone—Cough—Temozolomide—skin cancer	0.000752	0.00106	CcSEcCtD
Naltrexone—Paraesthesia—Bleomycin—skin cancer	0.000748	0.00105	CcSEcCtD
Naltrexone—Weight increased—Docetaxel—skin cancer	0.000748	0.00105	CcSEcCtD
Naltrexone—Vision blurred—Fluorouracil—skin cancer	0.000748	0.00105	CcSEcCtD
Naltrexone—Convulsion—Temozolomide—skin cancer	0.000746	0.00105	CcSEcCtD
Naltrexone—Vomiting—Imiquimod—skin cancer	0.000746	0.00105	CcSEcCtD
Naltrexone—Weight decreased—Docetaxel—skin cancer	0.000744	0.00104	CcSEcCtD
Naltrexone—Hypertension—Temozolomide—skin cancer	0.000744	0.00104	CcSEcCtD
Naltrexone—Dyspnoea—Bleomycin—skin cancer	0.000743	0.00104	CcSEcCtD
Naltrexone—Anorexia—Dactinomycin—skin cancer	0.000741	0.00104	CcSEcCtD
Naltrexone—Rash—Imiquimod—skin cancer	0.00074	0.00104	CcSEcCtD
Naltrexone—Dermatitis—Imiquimod—skin cancer	0.000739	0.00104	CcSEcCtD
Naltrexone—Pneumonia—Docetaxel—skin cancer	0.000737	0.00104	CcSEcCtD
Naltrexone—Headache—Imiquimod—skin cancer	0.000735	0.00103	CcSEcCtD
Naltrexone—Arthralgia—Temozolomide—skin cancer	0.000733	0.00103	CcSEcCtD
Naltrexone—Myalgia—Temozolomide—skin cancer	0.000733	0.00103	CcSEcCtD
Naltrexone—Infestation—Docetaxel—skin cancer	0.000733	0.00103	CcSEcCtD
Naltrexone—Infestation NOS—Docetaxel—skin cancer	0.000733	0.00103	CcSEcCtD
Naltrexone—Anxiety—Temozolomide—skin cancer	0.000731	0.00103	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000728	0.00102	CcSEcCtD
Naltrexone—Discomfort—Temozolomide—skin cancer	0.000725	0.00102	CcSEcCtD
Naltrexone—Decreased appetite—Bleomycin—skin cancer	0.000725	0.00102	CcSEcCtD
Naltrexone—Acute coronary syndrome—Docetaxel—skin cancer	0.000723	0.00102	CcSEcCtD
Naltrexone—Myocardial infarction—Docetaxel—skin cancer	0.000719	0.00101	CcSEcCtD
Naltrexone—Dry mouth—Temozolomide—skin cancer	0.000717	0.00101	CcSEcCtD
Naltrexone—Pain—Bleomycin—skin cancer	0.000713	0.001	CcSEcCtD
Naltrexone—Conjunctivitis—Docetaxel—skin cancer	0.000713	0.001	CcSEcCtD
Naltrexone—Confusional state—Temozolomide—skin cancer	0.000709	0.000996	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000708	0.000995	CcSEcCtD
Naltrexone—Oedema—Temozolomide—skin cancer	0.000703	0.000988	CcSEcCtD
Naltrexone—Anaphylactic shock—Temozolomide—skin cancer	0.000703	0.000988	CcSEcCtD
Naltrexone—Infection—Temozolomide—skin cancer	0.000699	0.000981	CcSEcCtD
Naltrexone—Nausea—Imiquimod—skin cancer	0.000697	0.000979	CcSEcCtD
Naltrexone—Hepatobiliary disease—Docetaxel—skin cancer	0.000693	0.000974	CcSEcCtD
Naltrexone—Epistaxis—Docetaxel—skin cancer	0.000692	0.000971	CcSEcCtD
Naltrexone—Nervous system disorder—Temozolomide—skin cancer	0.00069	0.000968	CcSEcCtD
Naltrexone—Convulsion—Fluorouracil—skin cancer	0.000688	0.000966	CcSEcCtD
Naltrexone—Feeling abnormal—Bleomycin—skin cancer	0.000687	0.000965	CcSEcCtD
Naltrexone—Skin disorder—Temozolomide—skin cancer	0.000683	0.000959	CcSEcCtD
Naltrexone—Hyperhidrosis—Temozolomide—skin cancer	0.00068	0.000955	CcSEcCtD
Naltrexone—Chest pain—Fluorouracil—skin cancer	0.000676	0.000949	CcSEcCtD
Naltrexone—Myalgia—Fluorouracil—skin cancer	0.000676	0.000949	CcSEcCtD
Naltrexone—Decreased appetite—Dactinomycin—skin cancer	0.000676	0.000949	CcSEcCtD
Naltrexone—Fatigue—Dactinomycin—skin cancer	0.00067	0.000941	CcSEcCtD
Naltrexone—Anorexia—Temozolomide—skin cancer	0.00067	0.000941	CcSEcCtD
Naltrexone—Discomfort—Fluorouracil—skin cancer	0.000668	0.000938	CcSEcCtD
Naltrexone—Pain—Dactinomycin—skin cancer	0.000665	0.000934	CcSEcCtD
Naltrexone—Urticaria—Bleomycin—skin cancer	0.000662	0.00093	CcSEcCtD
Naltrexone—Body temperature increased—Bleomycin—skin cancer	0.000659	0.000925	CcSEcCtD
Naltrexone—Hepatitis—Docetaxel—skin cancer	0.000658	0.000924	CcSEcCtD
Naltrexone—Confusional state—Fluorouracil—skin cancer	0.000653	0.000917	CcSEcCtD
Naltrexone—Pharyngitis—Docetaxel—skin cancer	0.000653	0.000917	CcSEcCtD
Naltrexone—Anaphylactic shock—Fluorouracil—skin cancer	0.000648	0.00091	CcSEcCtD
Naltrexone—Oedema—Fluorouracil—skin cancer	0.000648	0.00091	CcSEcCtD
Naltrexone—Connective tissue disorder—Docetaxel—skin cancer	0.000647	0.000908	CcSEcCtD
Naltrexone—Infection—Fluorouracil—skin cancer	0.000644	0.000904	CcSEcCtD
Naltrexone—Feeling abnormal—Dactinomycin—skin cancer	0.000641	0.0009	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000641	0.0009	CcSEcCtD
Naltrexone—Insomnia—Temozolomide—skin cancer	0.000636	0.000893	CcSEcCtD
Naltrexone—Gastrointestinal pain—Dactinomycin—skin cancer	0.000636	0.000893	CcSEcCtD
Naltrexone—Nervous system disorder—Fluorouracil—skin cancer	0.000635	0.000892	CcSEcCtD
Naltrexone—Tachycardia—Fluorouracil—skin cancer	0.000632	0.000888	CcSEcCtD
Naltrexone—Paraesthesia—Temozolomide—skin cancer	0.000631	0.000887	CcSEcCtD
Naltrexone—Dyspnoea—Temozolomide—skin cancer	0.000627	0.00088	CcSEcCtD
Naltrexone—Somnolence—Temozolomide—skin cancer	0.000625	0.000878	CcSEcCtD
Naltrexone—Anorexia—Fluorouracil—skin cancer	0.000618	0.000867	CcSEcCtD
Naltrexone—Eye disorder—Docetaxel—skin cancer	0.000615	0.000864	CcSEcCtD
Naltrexone—Abdominal pain—Dactinomycin—skin cancer	0.000615	0.000863	CcSEcCtD
Naltrexone—Body temperature increased—Dactinomycin—skin cancer	0.000615	0.000863	CcSEcCtD
Naltrexone—Hypersensitivity—Bleomycin—skin cancer	0.000614	0.000863	CcSEcCtD
Naltrexone—Decreased appetite—Temozolomide—skin cancer	0.000611	0.000858	CcSEcCtD
Naltrexone—Cardiac disorder—Docetaxel—skin cancer	0.000611	0.000858	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Temozolomide—skin cancer	0.000607	0.000853	CcSEcCtD
Naltrexone—Fatigue—Temozolomide—skin cancer	0.000606	0.000851	CcSEcCtD
Naltrexone—Pain—Temozolomide—skin cancer	0.000601	0.000845	CcSEcCtD
Naltrexone—Constipation—Temozolomide—skin cancer	0.000601	0.000845	CcSEcCtD
Naltrexone—Asthenia—Bleomycin—skin cancer	0.000598	0.00084	CcSEcCtD
Naltrexone—Angiopathy—Docetaxel—skin cancer	0.000597	0.000839	CcSEcCtD
Naltrexone—Immune system disorder—Docetaxel—skin cancer	0.000594	0.000835	CcSEcCtD
Naltrexone—Mediastinal disorder—Docetaxel—skin cancer	0.000593	0.000833	CcSEcCtD
Naltrexone—Chills—Docetaxel—skin cancer	0.000591	0.000829	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00059	0.000829	CcSEcCtD
Naltrexone—Pruritus—Bleomycin—skin cancer	0.00059	0.000828	CcSEcCtD
Naltrexone—Insomnia—Fluorouracil—skin cancer	0.000586	0.000823	CcSEcCtD
Naltrexone—Paraesthesia—Fluorouracil—skin cancer	0.000582	0.000817	CcSEcCtD
Naltrexone—Alopecia—Docetaxel—skin cancer	0.000582	0.000817	CcSEcCtD
Naltrexone—Feeling abnormal—Temozolomide—skin cancer	0.000579	0.000814	CcSEcCtD
Naltrexone—Dyspnoea—Fluorouracil—skin cancer	0.000578	0.000811	CcSEcCtD
Naltrexone—Mental disorder—Docetaxel—skin cancer	0.000577	0.00081	CcSEcCtD
Naltrexone—Somnolence—Fluorouracil—skin cancer	0.000576	0.000809	CcSEcCtD
Naltrexone—Gastrointestinal pain—Temozolomide—skin cancer	0.000575	0.000808	CcSEcCtD
Naltrexone—Malnutrition—Docetaxel—skin cancer	0.000573	0.000805	CcSEcCtD
Naltrexone—Hypersensitivity—Dactinomycin—skin cancer	0.000573	0.000804	CcSEcCtD
Naltrexone—Decreased appetite—Fluorouracil—skin cancer	0.000563	0.000791	CcSEcCtD
Naltrexone—Dysgeusia—Docetaxel—skin cancer	0.000561	0.000788	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000559	0.000786	CcSEcCtD
Naltrexone—Urticaria—Temozolomide—skin cancer	0.000559	0.000785	CcSEcCtD
Naltrexone—Asthenia—Dactinomycin—skin cancer	0.000558	0.000783	CcSEcCtD
Naltrexone—Abdominal pain—Temozolomide—skin cancer	0.000556	0.000781	CcSEcCtD
Naltrexone—Body temperature increased—Temozolomide—skin cancer	0.000556	0.000781	CcSEcCtD
Naltrexone—Back pain—Docetaxel—skin cancer	0.000554	0.000778	CcSEcCtD
Naltrexone—Pain—Fluorouracil—skin cancer	0.000554	0.000778	CcSEcCtD
Naltrexone—Muscle spasms—Docetaxel—skin cancer	0.000551	0.000774	CcSEcCtD
Naltrexone—Feeling abnormal—Fluorouracil—skin cancer	0.000534	0.00075	CcSEcCtD
Naltrexone—Diarrhoea—Dactinomycin—skin cancer	0.000532	0.000747	CcSEcCtD
Naltrexone—Vomiting—Bleomycin—skin cancer	0.00053	0.000744	CcSEcCtD
Naltrexone—Rash—Bleomycin—skin cancer	0.000526	0.000738	CcSEcCtD
Naltrexone—Dermatitis—Bleomycin—skin cancer	0.000525	0.000737	CcSEcCtD
Naltrexone—Hypersensitivity—Temozolomide—skin cancer	0.000518	0.000728	CcSEcCtD
Naltrexone—Urticaria—Fluorouracil—skin cancer	0.000515	0.000723	CcSEcCtD
Naltrexone—Syncope—Docetaxel—skin cancer	0.000514	0.000722	CcSEcCtD
Naltrexone—Body temperature increased—Fluorouracil—skin cancer	0.000512	0.000719	CcSEcCtD
Naltrexone—Palpitations—Docetaxel—skin cancer	0.000506	0.000711	CcSEcCtD
Naltrexone—Asthenia—Temozolomide—skin cancer	0.000504	0.000709	CcSEcCtD
Naltrexone—Loss of consciousness—Docetaxel—skin cancer	0.000504	0.000707	CcSEcCtD
Naltrexone—Cough—Docetaxel—skin cancer	0.0005	0.000702	CcSEcCtD
Naltrexone—Pruritus—Temozolomide—skin cancer	0.000497	0.000699	CcSEcCtD
Naltrexone—Convulsion—Docetaxel—skin cancer	0.000496	0.000697	CcSEcCtD
Naltrexone—Nausea—Bleomycin—skin cancer	0.000495	0.000695	CcSEcCtD
Naltrexone—Hypertension—Docetaxel—skin cancer	0.000495	0.000695	CcSEcCtD
Naltrexone—Vomiting—Dactinomycin—skin cancer	0.000494	0.000694	CcSEcCtD
Naltrexone—Rash—Dactinomycin—skin cancer	0.00049	0.000688	CcSEcCtD
Naltrexone—Chest pain—Docetaxel—skin cancer	0.000488	0.000685	CcSEcCtD
Naltrexone—Arthralgia—Docetaxel—skin cancer	0.000488	0.000685	CcSEcCtD
Naltrexone—Myalgia—Docetaxel—skin cancer	0.000488	0.000685	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000484	0.00068	CcSEcCtD
Naltrexone—Diarrhoea—Temozolomide—skin cancer	0.000481	0.000676	CcSEcCtD
Naltrexone—Hypersensitivity—Fluorouracil—skin cancer	0.000477	0.00067	CcSEcCtD
Naltrexone—Dry mouth—Docetaxel—skin cancer	0.000477	0.00067	CcSEcCtD
Naltrexone—Confusional state—Docetaxel—skin cancer	0.000471	0.000662	CcSEcCtD
Naltrexone—Anaphylactic shock—Docetaxel—skin cancer	0.000468	0.000657	CcSEcCtD
Naltrexone—Oedema—Docetaxel—skin cancer	0.000468	0.000657	CcSEcCtD
Naltrexone—Dizziness—Temozolomide—skin cancer	0.000465	0.000653	CcSEcCtD
Naltrexone—Infection—Docetaxel—skin cancer	0.000465	0.000652	CcSEcCtD
Naltrexone—Nausea—Dactinomycin—skin cancer	0.000462	0.000649	CcSEcCtD
Naltrexone—Shock—Docetaxel—skin cancer	0.00046	0.000646	CcSEcCtD
Naltrexone—Nervous system disorder—Docetaxel—skin cancer	0.000459	0.000644	CcSEcCtD
Naltrexone—Pruritus—Fluorouracil—skin cancer	0.000458	0.000644	CcSEcCtD
Naltrexone—Tachycardia—Docetaxel—skin cancer	0.000456	0.000641	CcSEcCtD
Naltrexone—Skin disorder—Docetaxel—skin cancer	0.000454	0.000638	CcSEcCtD
Naltrexone—Vomiting—Temozolomide—skin cancer	0.000447	0.000628	CcSEcCtD
Naltrexone—Anorexia—Docetaxel—skin cancer	0.000446	0.000626	CcSEcCtD
Naltrexone—Rash—Temozolomide—skin cancer	0.000443	0.000623	CcSEcCtD
Naltrexone—Diarrhoea—Fluorouracil—skin cancer	0.000443	0.000623	CcSEcCtD
Naltrexone—Dermatitis—Temozolomide—skin cancer	0.000443	0.000622	CcSEcCtD
Naltrexone—Headache—Temozolomide—skin cancer	0.00044	0.000619	CcSEcCtD
Naltrexone—Dizziness—Fluorouracil—skin cancer	0.000428	0.000602	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000426	0.000598	CcSEcCtD
Naltrexone—Insomnia—Docetaxel—skin cancer	0.000423	0.000594	CcSEcCtD
Naltrexone—Paraesthesia—Docetaxel—skin cancer	0.00042	0.00059	CcSEcCtD
Naltrexone—Nausea—Temozolomide—skin cancer	0.000418	0.000587	CcSEcCtD
Naltrexone—Dyspnoea—Docetaxel—skin cancer	0.000417	0.000586	CcSEcCtD
Naltrexone—Somnolence—Docetaxel—skin cancer	0.000416	0.000584	CcSEcCtD
Naltrexone—Vomiting—Fluorouracil—skin cancer	0.000412	0.000579	CcSEcCtD
Naltrexone—Rash—Fluorouracil—skin cancer	0.000408	0.000574	CcSEcCtD
Naltrexone—Dermatitis—Fluorouracil—skin cancer	0.000408	0.000573	CcSEcCtD
Naltrexone—Decreased appetite—Docetaxel—skin cancer	0.000406	0.000571	CcSEcCtD
Naltrexone—Headache—Fluorouracil—skin cancer	0.000406	0.00057	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Docetaxel—skin cancer	0.000404	0.000567	CcSEcCtD
Naltrexone—Fatigue—Docetaxel—skin cancer	0.000403	0.000566	CcSEcCtD
Naltrexone—Pain—Docetaxel—skin cancer	0.0004	0.000562	CcSEcCtD
Naltrexone—Constipation—Docetaxel—skin cancer	0.0004	0.000562	CcSEcCtD
Naltrexone—Feeling abnormal—Docetaxel—skin cancer	0.000385	0.000541	CcSEcCtD
Naltrexone—Nausea—Fluorouracil—skin cancer	0.000385	0.00054	CcSEcCtD
Naltrexone—Gastrointestinal pain—Docetaxel—skin cancer	0.000382	0.000537	CcSEcCtD
Naltrexone—Body temperature increased—Docetaxel—skin cancer	0.00037	0.000519	CcSEcCtD
Naltrexone—Abdominal pain—Docetaxel—skin cancer	0.00037	0.000519	CcSEcCtD
Naltrexone—Hypersensitivity—Docetaxel—skin cancer	0.000345	0.000484	CcSEcCtD
Naltrexone—Asthenia—Docetaxel—skin cancer	0.000335	0.000471	CcSEcCtD
Naltrexone—Pruritus—Docetaxel—skin cancer	0.000331	0.000465	CcSEcCtD
Naltrexone—Diarrhoea—Docetaxel—skin cancer	0.00032	0.000449	CcSEcCtD
Naltrexone—Dizziness—Docetaxel—skin cancer	0.000309	0.000434	CcSEcCtD
Naltrexone—Vomiting—Docetaxel—skin cancer	0.000297	0.000418	CcSEcCtD
Naltrexone—Rash—Docetaxel—skin cancer	0.000295	0.000414	CcSEcCtD
Naltrexone—Dermatitis—Docetaxel—skin cancer	0.000295	0.000414	CcSEcCtD
Naltrexone—Headache—Docetaxel—skin cancer	0.000293	0.000411	CcSEcCtD
Naltrexone—Nausea—Docetaxel—skin cancer	0.000278	0.00039	CcSEcCtD
